Investment Banking

KKR's pharma sale caps a bumper year for European buyers

US investment banks Jefferies and Goldman Sachs share credit as lead advisers

KKR's pharma sale caps a bumper year for European buyers

The acquisition of Capsugel, a drug capsule-maker owned by private equity giant KKR, by the Swiss pharmaceuticals firm Lonza Group for $5.5 billion caps the best year for European companies acquiring US rivals since 2000.

Lonza, which was advised by US investment bank Jefferies on the deal, is aiming to beef up its drug-delivery capabilities with the acquisition of Capsugel, which specialises in capsules.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire